Completed
A Study of Patients Receiving Adjuvant Nivolumab Therapy for Melanoma That Has Been Removed - CA209-8RX
Aggiornato:
1 giugno, 2026
|
ClinicalTrials.gov
Sintesi in un linguaggio semplice